Dois-je éviter retinoyl tetrapeptide-43 amide pendant la grossesse ? | VeriMom
No harmonised CLP reproductive classification (no entry in ECHA Annex VI) and no CIR or SCCS safety assessment found for this specific ingredient (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, CosIng, PubChem). However, the molecule contains a retinoyl (retinoid) moiety, which is a structural/class-based theoretical concern for developmental toxicity; there are no animal or human reproductive data for this specific peptide to elevate the hazard score. Topical peptide with large molecular weight and amide linkage suggests negligible systemic absorption under typical cosmetic use (hence exposure scored 0).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- retinoyl tetrapeptide-43 amide est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (no entry in ECHA Annex VI) and no CIR or SCCS safety assessment found for this specific ingredient (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, CosIng, PubChem). However, the molecule contains a retinoyl (retinoid) moiety, which is a structural/class-based theoretical concern for developmental toxicity; there are no animal or human reproductive data for this specific peptide to elevate the hazard score. Topical peptide with large molecular weight and amide linkage suggests negligible systemic absorption under typical cosmetic use (hence exposure scored 0).
- retinoyl tetrapeptide-43 amide est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: theoretical class-based concern due to retinoyl group but no specific reproductive or lactation transfer data. No regulatory harmonised flags or CIR/SCCS opinion for this ingredient. Expected topical absorption negligible, so low likelihood of significant transfer into breastmilk absent data.
- retinoyl tetrapeptide-43 amide est-il sûr pour la peau de bébé ?
- Hazard and mechanism remain theoretical (retinoid moiety) with no infant-specific data. Exposure increased by +1 relative to adult because infant skin has higher permeability and surface-area-to-weight, and although adult topical absorption is expected negligible, infant exposure is considered low but measurable in absence of definitive absorption data.
- Comment VeriMom évalue-t-il retinoyl tetrapeptide-43 amide ?
- VeriMom évalue retinoyl tetrapeptide-43 amide à 13/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à retinoyl tetrapeptide-43 amide pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à retinoyl tetrapeptide-43 amide basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.